PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 93 filers reported holding PLIANT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,479,627 | -31.2% | 281,189 | -50.0% | 0.79% | -41.7% |
| Q4 2022 | $10,870,786 | -7.5% | 562,379 | 0.0% | 1.35% | -7.8% |
| Q3 2022 | $11,748,000 | +160.8% | 562,379 | 0.0% | 1.46% | +180.1% |
| Q2 2022 | $4,505,000 | +14.3% | 562,379 | 0.0% | 0.52% | +31.2% |
| Q1 2022 | $3,942,000 | -48.1% | 562,379 | 0.0% | 0.40% | -44.2% |
| Q4 2021 | $7,592,000 | -20.0% | 562,379 | 0.0% | 0.71% | +28.2% |
| Q3 2021 | $9,493,000 | -42.0% | 562,379 | 0.0% | 0.56% | -41.0% |
| Q2 2021 | $16,376,000 | -26.0% | 562,379 | 0.0% | 0.94% | -23.8% |
| Q1 2021 | $22,118,000 | +73.1% | 562,379 | 0.0% | 1.24% | +78.4% |
| Q4 2020 | $12,777,000 | +0.3% | 562,379 | 0.0% | 0.69% | -1.0% |
| Q3 2020 | $12,738,000 | -30.2% | 562,379 | 0.0% | 0.70% | -55.0% |
| Q2 2020 | $18,255,000 | – | 562,379 | – | 1.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
| CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
| TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
| Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
| Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
| Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
| HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
| Grace Capital | 48,058 | $808,000 | 0.50% |
| Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
| Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |